HIV & AIDS

Experimental mRNA HIV vaccine safe, shows promise in animals

An experimental HIV vaccine based on mRNA—the same platform technology used in two highly effective COVID-19 vaccines—shows promise in mice and non-human primates, according to scientists at the National Institute of ...

HIV & AIDS

Uncontrolled HIV could be behind COVID-19 variants in Africa

Failure to get COVID-19 vaccines to countries with high rates of uncontrolled advanced HIV could lead to the emergence of new variants, write Nokukhanya Msomi, Richard Lessells and colleagues in a Comment in this week's Nature. ...

Diseases, Conditions, Syndromes

One coronavirus vaccine may protect against other coronaviruses

Northwestern Medicine scientists have shown for the first time that coronavirus vaccines and prior coronavirus infections can provide broad immunity against other, similar coronaviruses. The findings build a rationale for ...

Vaccination

J&J's HIV vaccine fails in sub-Saharan Africa trial

Johnson & Johnson's highly anticipated HIV vaccine failed to demonstrate adequate protection in a clinical trial involving more than 2,600 young women in sub-Saharan Africa, the company and US health authorities said Tuesday.

Vaccination

Novel HIV vaccine trial starts at Oxford

The University of Oxford today started vaccinations of a novel HIV vaccine candidate as part of a Phase I clinical trial in the UK.

page 5 from 27